Mei He, MD
Neurology · Dakota Dunes, SDNPI 1790982395
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,257 of the $4,697 with a category attached, or 69.3%. Inspire Medical Systems, Inc. accounts for 62.9% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $3,014 and has fallen 71.1% since, to $870 in 2025.
Across 114 payments — averaging $41.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- AbbVie$556
- Itamar Medical Inc$322
- Teva Pharmaceuticals USA, Inc.$125
- SK Life Science, Inc.$123
- Abbott$93
- plus $523 from 13 others
What the payments were for
- Travel & lodging$1,44031%
- Food & beverage$3,25769%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 27 | $2,954 |
| AbbVie(2 entities) | 47 | $556 |
| Itamar Medical Inc | 2 | $322 |
| Teva Pharmaceuticals USA, Inc. | 3 | $125 |
| SK Life Science, Inc. | 6 | $123 |
| Abbott | 5 | $93 |
| Lundbeck LLC | 4 | $86 |
| Lilly USA, LLC | 4 | $63 |
| Merz Pharmaceuticals, LLC | 2 | $55 |
| Acadia Pharmaceuticals Inc | 2 | $53 |
| Argenx US, Inc. | 2 | $50 |
| Amneal Pharmaceuticals LLC | 2 | $41 |
| GE HealthCare | 2 | $36 |
| Neurelis, Inc. | 1 | $35 |
| Jazz Pharmaceuticals Inc. | 1 | $33 |
| Impel Pharmaceuticals Inc. | 1 | $25 |
| AstraZeneca | 1 | $16 |
| Pfizer | 1 | $15 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,425
- WatchPATONE$322
How this compares
$4,697 in reported general payments places this provider in the 80th percentile of 49 neurology providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 22 | $34,509 |
| BriviactBrivaracetam | 19 | $27,111 |
| ZonegranZonisamide | 14 | $26,648 |
| Levetiracetam | 113 | $2,591 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 59 | $1,741 |
| Divalproex Sodium | 36 | $898 |
| Gabapentin | 67 | $837 |
| Clorazepate Dipotassium | 12 | $679 |
| Propranolol Hcl ErPropranolol Hcl | 24 | $560 |
| Baclofen | 35 | $483 |
| Levetiracetam ErLevetiracetam | 16 | $451 |
| Topiramate | 62 | $313 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 13 | $306 |
| Donepezil Hcl | 37 | $299 |
| Lamotrigine | 20 | $238 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $556 | $34,50922 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 49 neurology providers in South Dakota.
Other neurology in Dakota Dunes
- James CaseDakota Dunes$3K
- Jon GrudemNorth Sioux City$293K
- Andrew RidderSioux Falls$97K
- Wijdan RaiSioux Falls$81K
- Carol NelsonMitchell$60K
- Jennifer KrugerRapid City$19K
- Jeffrey BoyleSioux Falls$14K
- Mehwish FarooqiSioux Falls$12K
- Bassel SalemSioux Falls$7K
- Cynthia Zevallos MauSioux Falls$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.